SABA inhaler carbon emissions drop by one-third
NHS England data has shown that average emissions for short-acting beta-2 agonist (SABA) inhalers prescribed in primary care declined by 33% between 2020 and November 2024 — from 24.2 kgCO2e to 16.1 kgCO2e. The Pharmaceutical Journal reports that this fall in SABA inhaler emissions most likely owes to patients switching from the Ventolin Evohaler to the Salamol inhaler.
NICE has produced a decision aid on asthma inhalers and climate change. It explains the options for patients thinking about reducing the carbon footprint of their asthma treatment and the options available.
Related Posts
The Medical Examiner
A new statutory medical examiner system is being rolled out across England and Wales to provide independent scrutiny of deaths, and to…
Data Security Protection Toolkit (DSPT) for 2024-25
Why complete a DSPT assessment? All organisations that have access to NHS patient information must provide assurances that they have…
Repeat Prescribing Toolkit
This resource was commissioned by NHS England to address recommendation 7 of the National Overprescribing Review, which tasked the Royal Pharmaceutical…